Related Experiment Videos
The dilemma of the prolonged QT interval in early drug studies
M Thomas1, J G Maconochie, E Fletcher
1Clinical Pharmacology and Dynamics Department, Glaxo Research and Development Ltd, Ware, Hertfordshire.
British Journal of Clinical Pharmacology
|February 1, 1996
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Measurement of Reactor Antineutrino Oscillation at SNO.
Physical review letters·2025
The impact of the COVID-19 pandemic on first-episode psychosis presentations in two early intervention in psychosis services.
Irish journal of psychological medicine·2024
Lattice distortions and the metal-insulator transition in pure and Ti-substituted Ca3Ru2O7.
Journal of physics. Condensed matter : an Institute of Physics journal·2022
Profiling of donor-specific immune effector signatures in response to rituximab in a human whole blood loop assay using blood from CLL patients.
International immunopharmacology·2020
[Intra-cardiac manifestation during adult-onset Still's disease's, a tricuspid vegetation as a rare expression of systemic disease].
La Revue de medecine interne·2018
Cannabis-based medicines: On the topic of intoxication.
British journal of clinical pharmacology·2026
Machine learning framework for prediction of drug-induced liver injury in patients on antitubercular therapy: Multicentric study.
British journal of clinical pharmacology·2026
Translational development of crisugabalin for neuropathic pain.
British journal of clinical pharmacology·2026
Physiologically based pharmacokinetic modelling of levofloxacin as a tool for paediatric dose optimization.
British journal of clinical pharmacology·2026
Patient-reported outcomes and medication errors during oral antitumour therapy in paediatrics: Results from the youngAMBORA care programme.
British journal of clinical pharmacology·2026
Analysis of clinical investigation (device) initial submissions received by the Medicines and Healthcare products Regulatory Agency between January 2022 and December 2025.
British journal of clinical pharmacology·2026
A review of FDG-PET biomarker analysis methods in Parkinson's disease.
Journal of Parkinson's disease·2026
Mapping Pharmacogenomic Determinants of Adverse Drug Reactions in Hypertension: A Systematic Review.
Pharmaceuticals (Basel, Switzerland)·2026
Development and Evaluation of Physiologically Based Pharmacokinetic (PBPK) Models of Metoclopramide Across the Lifespan: Translation from Adults to Infants.
Pharmaceuticals (Basel, Switzerland)·2026